Penny Stock at Bottom of Nasdaq After Scrapped Drug Plans

Zafgen halted plans for another experimental drug

Managing Editor
Mar 12, 2019 at 10:30 AM
facebook X logo linkedin

The shares of Zafgen Inc (NASDAQ:ZFGN) are down 32.2% to trade at $3.43, one of the worst stocks on the Nasdaq this morning, under pressure from a double-dose of negative headlines. First, the drugmaker pulled plans for its experimental drug for rare diseases due to anomalies in animal trial data. What's more, the company announced its Chief Medical Officer resigned, effectively immediately.

Zafgen stock earlier tapped a fresh two-year low of $3.19. ZFGN was destroyed late in 2018 after another of its experimental drugs was put on clinical hold by the Food and Drug Administration (FDA). After that late-November bear gap, the equity spent most of the time consolidating below the $5.50 mark. Even prior to today's drop, ZFGN had shed 7% in 2019. 

Leerink responded to the news today with a price-target cut to $6 from $9. There could be plenty more bearish analyst attention on the way, too. Exactly three-quarters of the brokerages in coverage rate ZFGN a "strong buy," with zero "sells on the books. Plus, the stock's consensus 12-month price target of $8.40 is a 82.6% premium from last night's closing perch at $4.60. 

There's also ample room aboard the bearish bandwagon. Short interest increased by 5.6% in the most recent reporting period, but the 2.9 million shares sold short is less than half the 2018 highs. Plus, it only represents a slim 2.4% of ZFGN's total available float. Today's drop puts the stock on the short-sale restricted list, however.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI